ORN0829 hydrate
tetrakis([(2S)-2-[[3-(5-fluoro-2-pyridinyl)pyrazol-1-yl]methyl]-1,3-oxazinan-3-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone);hydrate
Molecular Identity
ORN0829 hydrate
tetrakis([(2S)-2-[[3-(5-fluoro-2-pyridinyl)pyrazol-1-yl]methyl]-1,3-oxazinan-3-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone);hydrate
PubChem CID: 154572855
2D Structure
Properties
C92H90F4N28O9
Molecular Formula
1807.90
Molecular Weight
g/mol
1806.7382
Exact Mass
Da
365
TPSA
May have limited oral absorption
1
H-Bond Donors
29
H-Bond Acceptors
667
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(13)
ORN0829 hydrateORN-0829 hydrateO67SLE6VA32265899-50-9Ts-142Methanone, ((2S)-2-((3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl)methyl)dihydro-2H-1,3-oxazin-3(4H)-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)-, hydrate (4:1)RefChem:168554orexin receptor antagonist TS-142UNII-O67SLE6VA31793073-93-4Vornorexant hydrate (JAN)D12611(S)-(2-((3-(5-FLuoropyridin-2-yl)-1H-pyrazol-1-yl)methyl)-1,3-oxazinan-3-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone hydrate(4:1)
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to ORN0829 hydrate
Loading drug network...